Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

MM5: Guidance on Clinical Management of Mild to Moderate COVID-19

In this presentation, Dr. Adaora Adimora discusses medical management for mild to moderate COVID-19, including current treatment recommendations and data on investigational therapies.
Ada Adimora, MD, MPH
Released: June 18, 2020

Information on this Educational Activity

Faculty

Ada Adimora, MD, MPH

Sarah Graham Kenan Distinguished Professor of Medicine
Attending

Division of Infectious Diseases
Department of Medicine
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Adaora A. Adimora, MD, MPH, has disclosed that she has received funds for research support from Gilead Sciences and consulting fees from Gilead Sciences, Merck, and ViiV Healthcare.

Program Medium

This program has been made available online.

Related Content

From Clinical Care Options (CCO) and Dr. Dalilah Restrepo: guidance on use of the recombinant zoster vaccine (RZV) to prevent shingles complications

person default Dalilah Restrepo, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: November 10, 2021 Expired: November 9, 2022

Download key slides on guidance and CDC recommendations on vaccination to prevent shingles and its complications in the COVID-19 era.

person default Dalilah Restrepo, MD Released: November 10, 2021

Expert commentary on incorporating lessons from the COVID-19 pandemic into improving HCV care among vulnerable populations, from Dr. Gregory Dore and Clinical Care Options (CCO)

Gregory Dore, MBBS, PhD, FRACP, MPH Released: November 8, 2021

Download slides reviewing the latest data and guidance on COVID-19 treatments, including authorized and investigational agents, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: November 4, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue